Jens Bredal Nielsen

Title: The Innovations of Jens Bredal Nielsen

Introduction

Jens Bredal Nielsen is a prominent inventor based in Charlottenlund, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of resveratrol through metabolically engineered cells. With a total of 10 patents to his name, Nielsen's work has garnered attention for its potential applications in health and wellness.

Latest Patents

Nielsen's latest patents focus on the development of recombinant micro-organisms capable of producing resveratrol. One notable patent describes a pathway where phenylalanine ammonia lyase (PAL) converts phenylalanine into trans-cinnamic acid. This process is followed by the action of cinnamate 4-hydroxylase (C4H), which produces 4-coumaric acid, and subsequently, 4-coumarate-CoA ligase (4CL) generates 4-coumaroyl CoA. Finally, resveratrol synthase (VST) synthesizes resveratrol from 4-coumaroyl CoA. The micro-organisms involved in this process may include yeast, fungi, or bacteria.

Career Highlights

Throughout his career, Jens Bredal Nielsen has worked with notable companies such as Fluxome Sciences A/S and Evolva SA. His expertise in metabolic engineering has positioned him as a key figure in the biotechnology sector, where he continues to innovate and develop new methods for producing valuable compounds.

Collaborations

Nielsen has collaborated with esteemed colleagues, including Jochen Förster and Michael Katz. These partnerships have further enhanced his research and development efforts, leading to advancements in the field.

Conclusion

Jens Bredal Nielsen's contributions to biotechnology, particularly in the production of resveratrol, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to inspire future developments in the industry.